Physician profile
Michelle Selene Wright
NPI 1982364394
$4,650.28
in general payments reported to CMS, 2019-2025
16 companies · $2,204 in 2025
The $2,204 reported for 2025 was more than what 94% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $13.27 · 2023: $1,596 · 2024: $837 · 2025: $2,204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,622 · Travel and Lodging: $1,628 · Education: $387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,621.97 |
| Travel and Lodging | $1,627.74 |
| Education | $387.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,102.17 | 2023-2025 | Linq II, Cobalt Dr Mri Surescan, Micra |
| Cvrx, INC. | $1,699.23 | 2023-2025 | Barostim Neo System |
| Impulse Dynamics (USA) INC. | $162.04 | 2023 | Optimizer |
| Novartis Pharmaceuticals Corporation | $143.04 | 2023-2024 | |
| Abbvie INC. | $133.34 | 2022-2024 | |
| Edwards Lifesciences Corporation | $113.56 | 2025 | Evoque |
| Abbott Laboratories | $67.76 | 2023-2025 | Aveir, Mitraclip |
| Janssen Pharmaceuticals, INC | $42.74 | 2023 | Xarelto |
| Merck Sharp & Dohme LLC | $39.93 | 2023-2024 | Verquvo |
| Regeneron Healthcare Solutions, INC. | $25.46 | 2024 | Evkeeza, Praluent |
| Kiniksa Pharmaceuticals, LTD. | $23.88 | 2023 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.37 | 2023 | Jardiance |
| Daiichi Sankyo INC. | $21.53 | 2023 | Injectafer |
| Scpharmaceuticals INC. | $19.94 | 2023 | |
| Biotronik INC. | $18.30 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $13.99 | 2024 | Tridyne Vascular Sealant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.